Drug Shortage Report for PMS-RABEPRAZOLE EC

Last updated on 2018-10-03 History
Report ID 59122
Drug Identification Number 02310805
Brand name PMS-RABEPRAZOLE EC
Common or Proper name RABEPRAZOLE
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 10MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-10-01
Actual start date
Estimated end date
Actual end date 2018-09-30
Shortage status Avoided shortage
Updated date 2018-10-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-10-03 French Compare
v4 2018-10-03 English Compare
v3 2018-10-02 English Compare
v2 2018-08-24 French Compare
v1 2018-08-24 English Compare

Showing 1 to 5 of 5